Acrivon Therapeutics
Biotech company specializing in drug development through early clinical treatment success. Learn more
Launch date
Employees
Market cap
AUD426m
Enterprise valuation
AUD154m (Public information from Sep 2024)
Share price
$7.59 ACRV
Cambridge Massachusetts (HQ)
Authorizing premium user...